Dr. Narikazu Boku Gastrointestinal Medical Oncology


Deputy Director - National Cancer Center Hospital, Japan , Experience:

Book Appointment

About Doctor

Dr. Narikazu Boku is among the leading and top GI cancer expert in Tokyo, Japan.

Dr. Narikazu Boku is from department of Gastrointestinal Medical Oncology and is Deputy Director, National Cancer Center Hospital, Japan.

The division of Gastrointestinal Medical Oncology focuses on the development of new drugs and establishment of standard chemotherapy regimens including multimodality treatment with surgery and/or radiotherapy for advanced esophageal/gastric/colorectal cancers, gastrointestinal stromal tumor, and other gastrointestinal (GI) malignancies. The team does not only participate in many industry-sponsored trials but also conduct investigator-initiated trials, which are associated with translational research, in collaboration with many clinicians and basic researchers in Japan, Asia, and worldwide. Recently, the team has investigated biomarkers using pretreatment tumor and blood samples, including circulating tumor cell and cell-free DNA. Because easy access to tumor samples by endoscopy is a strong point in GI malignancy, the team is now preceding to translational research using repeated biopsy samples after administering investigational drugs.

Hospital

National Cancer Centre, Japan

Specialization

Gastrointestinal Medical Oncology

Procedures Performed

  • Gastrointestinal Medical Oncology
  • GI Cancer
  • Esophageal Cancer
  • Stomach Cancer

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
Need help with cancer treatment?
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy